-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Pharmaceutical Co Sees FY2026 Adj EPS $3.01; Sees Sales $29.585B

Benzinga·05/13/2026 10:59:39
Listen to the news

Takeda Pharmaceutical Co (NYSE:TAK) is looking for FY2026 Adj EPS of $3.01. sees sales of $29.585 billion.